Skip to main content
. 2022 Nov 14;12(11):2791. doi: 10.3390/diagnostics12112791

Table 1.

Performance of the developed approach using MRI dataset (Unit %).

Illnesses FS MN GL VD CA HY CC MA CS MI AD CT ME PD SR AL CJ MB AV MS LE HE CH HD NB
FS 96 0 0 0 1 0 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0
MN 0 98 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0
GL 1 0 99 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
VD 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
CA 0 0 1 0 95 0 0 2 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1
HY 2 0 0 0 0 93 0 0 0 0 0 2 0 0 1 0 0 0 0 0 0 2 0 0 0
CC 0 0 0 0 0 1 99 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
MA 0 0 0 0 2 0 0 97 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
CS 0 1 0 0 0 0 1 0 96 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0
MI 1 0 0 1 0 0 0 0 2 94 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0
AD 0 0 0 0 0 0 0 0 0 1 97 0 0 0 0 2 0 0 0 0 0 0 0 0 0
CT 0 0 1 0 0 0 0 0 0 0 0 98 1 0 0 0 0 0 0 0 0 0 0 0 0
ME 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0
PD 2 0 0 1 0 0 0 1 0 0 0 0 0 94 0 0 0 0 0 0 0 0 0 0 2
SR 0 0 0 0 1 0 0 0 0 0 2 0 0 0 96 1 0 0 0 0 0 0 0 0 0
AL 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 97 0 0 2 0 0 0 0 0 0
CJ 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 99 0 0 0 0 0 0 0 0
MB 1 0 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 94 0 0 0 0 2 0 0
AV 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 0 1 95 0 0 0 0 1 0
MS 0 0 1 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 0 96 0 0 0 0 0
LE 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 98 0 0 0 0
HE 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 99 0 0 0
CH 0 1 0 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 94 0 0
HD 2 0 0 1 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 1 0 0 0 93 1
NB 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 97
Average 96.58%